A-05: Short pulse laser system for the treatment of age-related macular degeneration
Developing a laser procedure (frequency-doubled Nd:YAG solid-state lasers) for treating pathological changes in the retinal pigment epithelium in connection with age-related macula degeneration. For the first time ever, the product to be developed will provide a treatment option for the early form of age-related macula degeneration, which progressively leads to a loss of central vision and, with it, the ability to read. In Germany alone, a one-off market for up to 3,000,000 people can be expected for this indication.
The goal is to develop a system that has decisive advantages over existing systems. The current state-of-the-art is based on an elaborate and expensive procedure for injecting the patient with a dye via the bloodstream and then firing a laser light adjusted to the dye at the ocular fundus. However, beyond this, the project could lead to a procedure that enables treatment of the dry form of AMD, which cannot be treated by enriching the dye in the blood vessels. The system should enable the application of short laser pulses in the microsecond range; these minimize thermal damage to the retina.
01.07.2010 - 30.06.2013
- A.R.C. Laser GmbH
- Universitätsklinikum Erlangen
Kommentieren Sie diesen Beitrag und diskutieren Sie mit anderen Akteuren in der Medical Valley-Community auf Xing.
Wir freuen uns auf Sie!